iBio Gross Profit Margin (Quarterly) Insights

iBio Inc (IBIO)

1.78 +0.06 (+3.49%) USD | NYAM | Apr 22, 16:00

1.79 +0.01 (+0.56%) After-Hours: 20:00

Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2007. Upgrade now.

Date	Value
June 30, 2021	61.91%
March 31, 2021	35.56%
December 31, 2020	70.07%
September 30, 2020	73.90%
June 30, 2020	73.30%
March 31, 2020	10.42%
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015

Date	Value
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011
September 30, 2011
June 30, 2011
March 31, 2011
December 31, 2010
September 30, 2010
June 30, 2010
March 31, 2010
December 31, 2009
September 30, 2009
June 30, 2009	97.28%
March 31, 2009	49.10%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

10.42%

Minimum

Mar 2020

73.90%

Maximum

Sep 2020

54.19%

Average

65.99%

Median

Gross Profit Margin (Quarterly) Benchmarks

Lixte Biotechnology Holdings Inc	--
PAVmed Inc	-53.57%
Avalo Therapeutics Inc	--
Imunon Inc	--
Ocugen Inc	--